Angelman syndrome: current understanding and research prospects.
about
Exome sequencing reveals new causal mutations in children with epileptic encephalopathiesDrosophila modeling of heritable neurodevelopmental disordersControl of synapse development and plasticity by Rho GTPase regulatory proteins.Pathology from evolutionary conflict, with a theory of X chromosome versus autosome conflict over sexually antagonistic traits.Palate morphogenesis: current understanding and future directions.Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitorsMaternal Ube3a Loss Disrupts Sleep Homeostasis But Leaves Circadian Rhythmicity Largely Intact.Potential therapeutic approaches for Angelman syndrome.Relationship between aberrant brain connectivity and clinical features in Angelman Syndrome: a new method using tract based spatial statistics of DTI color-coded orientation maps.Epilepsy in patients with Angelman syndrome.Are children with Angelman syndrome at high risk for anesthetic complications?Genetic and epigenetic dysregulation of imprinted genes in the brain.Epilepsy in four genetically determined syndromes of intellectual disability.Angelman syndrome: review of clinical and molecular aspects.Phenotypic plasticity and the perception-action-cognition-environment paradigm in neurodevelopmental genetic disorders.Specificity and disease in the ubiquitin systemmTORC1-S6K1 inhibition or mTORC2 activation improves hippocampal synaptic plasticity and learning in Angelman syndrome miceEphecting excitatory synapse development.[Anesthesia and Angelman syndrome].Impaired Neurite Contact Guidance in Ubiquitin Ligase E3a (Ube3a)-Deficient Hippocampal Neurons on Nanostructured Substrates.Rett Syndrome.Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model.Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant gene associated with Angelman syndrome
P2860
Q24604206-A778B805-55FF-4C47-A2C0-BAF1FC218B5FQ34629298-401A30F5-6E99-48A9-8FA9-CD4587715329Q35084942-DDAA37E8-7D6A-49E4-8ACA-88E6BEDF5A6FQ35092394-BEFB6CD2-F4DF-49CD-B473-8810CDD8ABC2Q35111595-3DD5779A-1510-4019-8AE7-A7B8BBDD4E63Q35187482-F84E1B9C-13C4-4F12-95F6-1C5FA66E8028Q36010566-C90F7EB4-3363-4B12-9841-47A13BBB0E53Q36128318-FECF8EFA-479F-4EAC-B56F-8113E75BA792Q36992786-789EA1F4-7252-4A13-9A4B-D946F7D1E0F4Q37404219-7CB4D26D-A3DC-44B0-B506-BED90F7125AEQ37732476-2B7B7849-02BE-4659-9613-E2E91FCD0F88Q37908172-5B3AB333-643E-45C3-B4AD-400C93EF29E9Q37961799-5E3E231B-B0DE-44C7-B4DC-8E4B6FA11AF8Q37964799-99874BD1-EAC5-4090-919A-EB5A840838BBQ38216017-E36A71BD-1CE2-4E47-A364-FEE715D1E883Q38358919-365AB588-1A83-41DB-A612-0F7BEBB19DDAQ38728113-4C9B1578-2EDB-47C3-BFCE-F2C333E4EDDDQ41378038-87EF0423-08E1-4932-BA3A-ABC6540CCE52Q42375076-ECDC6FC3-F84D-4638-82A7-A113E2335CE0Q51878162-4B8A7FE5-6B01-4D00-AAAD-31D5C778B479Q52144715-4F92AB9E-A848-447E-9319-15E2E8F3F04FQ55056221-BCF053E7-EC02-4AF6-9FC8-AD8094436CB2Q55228979-A5361258-323A-40B8-8021-5378451D1732Q57168803-47C55484-FAC7-4267-B9C7-3FE524EA9060
P2860
Angelman syndrome: current understanding and research prospects.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Angelman syndrome: current understanding and research prospects.
@en
Angelman syndrome: current understanding and research prospects.
@nl
type
label
Angelman syndrome: current understanding and research prospects.
@en
Angelman syndrome: current understanding and research prospects.
@nl
prefLabel
Angelman syndrome: current understanding and research prospects.
@en
Angelman syndrome: current understanding and research prospects.
@nl
P1433
P1476
Angelman syndrome: current understanding and research prospects
@en
P2093
Bernard Dan
P304
P356
10.1111/J.1528-1167.2009.02311.X
P50
P577
2009-11-01T00:00:00Z